← Leaderboards
Christopher Henderson
Columbia University Health Sciences
$3,778,516
Attributed
$8,033,797
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2007–13$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$9,673,372 · 6
By mechanism
RC2$3,782,000 · 1
U24$3,279,150 · 2
R01$2,372,222 · 2
R21$240,000 · 1
Top collaborators
- Kevin C Eggan7 shared
- Thomas P Maniatis7 shared
- Jeffrey D Rothstein7 shared
- Merit E Cudkowicz3 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Mercy M Davidson$2,733,556
- Diane Berengere Re$7,904,391
- Domenico Accili$45,709,534
- Ira A Tabas$44,847,082
- Alan Richard Tall$42,229,886
Others in their field
Top investigators on “Amyotrophic Lateral Sclerosis”
- Merit E Cudkowicz · Massachusetts General Hospital$54,029,758
- James Dale Berry · Brigham And Women'S Hospital$37,291,450
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
- Suma Babu · Massachusetts General Hospital$36,168,406
- Jeffrey D Rothstein · Massachusetts General Hospital$22,909,620
- Teepu Siddique · University Of Chicago$22,641,778
Research focus
Amyotrophic Lateral SclerosisMutationCellsAstrocytesSiteLeadCell TypeProteinsInsightMotor NeuronsPathway InteractionsMutantBaseSignal TransductionSpinal CordEmbryoIn VitroNeuronsIn VivoResearch StudyMonitorResponseDisease ProgressionAnimal Model
Grant awards (16)
Generation and Characterization of Amyotrophic Lateral Sclerosis$789,962
U24 · FY2013 · NS
New hiPSC tools for astroglial-focused approaches to ALS$789,962
U24 · FY2013 · NS
Role of MMP-9 in selective motor neuron degeneration in ALS$348,480
R01 · FY2013 · NS · contact PI
Evaluating HMG-CoA reductase as a therapeutic target in ALS$240,000
R21 · FY2013 · NS · contact PI
Generation and Characterization of Amyotrophic Lateral Sclerosis$849,613
U24 · FY2012 · NS
New hiPSC tools for astroglial-focused approaches to ALS$849,613
U24 · FY2012 · NS
Role of Fas death receptor signaling in motor neuron degeneration$345,144
R01 · FY2011 · NS · contact PI
Generation and Characterization of Amyotrophic Lateral Sclerosis iPS cells$1,837,375
RC2 · FY2010 · NS
Role of Fas death receptor signaling in motor neuron degeneration$348,666
R01 · FY2010 · NS · contact PI
Generation and Characterization of Amyotrophic Lateral Sclerosis iPS cells$82,000
RC2 · FY2010 · NS
Generation and Characterization of Amyotrophic Lateral Sclerosis iPS cells$1,862,625
RC2 · FY2009 · NS
Role of Fas death receptor signaling in motor neuron degeneration$352,188
R01 · FY2009 · NS · contact PI
Role of Fas death receptor signaling in motor neuron degeneration$256,998
R01 · FY2009 · NS · contact PI
Role of Fas death receptor signaling in motor neuron degeneration$16,370
R01 · FY2009 · NS · contact PI
Role of Fas death receptor signaling in motor neuron degeneration$352,188
R01 · FY2008 · NS · contact PI
Role of Fas death receptor signaling in motor neuron degeneration$352,188
R01 · FY2007 · NS · contact PI